Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Champ Resto Indonesia Tbk. (ENAK) vs Indofarma Tbk. (INAF)

Champ Resto Indonesia Tbk.Trading
Indofarma Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Champ Resto Indonesia Tbk. dan Indofarma Tbk.: Champ Resto Indonesia Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 494 M, volume 24 jam 437,2 rb), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Champ Resto Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

ENAKINAF
Kapitalisasi Pasar
494 M390,51 M
Volume
437,2 rb
Lot
4,37 rb
Perputaran
97,63 jt
Harga Rata-rata
223,3
Nilai Transaksi
97,63 jt
Harga Ekuilibrium Indikatif
224
Volume Ekuilibrium Indikatif
10

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ENAK
Lihat detail
INAF
Lihat detail

Tentang Champ Resto Indonesia Tbk.

PT Champ Resto Indonesia Tbk ("Company") was established based on the Notarial Deed of Catherina Situmorang, S.H., No. 20 dated March 22, 2010.

Selengkapnya di halaman ENAK

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF